Tinnitus.
D001241:Aspirin / Q000009:adverse effects; D002220:Carbamazepine / Q000627:therapeutic use; D004427:Ear Diseases / Q000150:complications; D004599:Electric Stimulation Therapy; D006317:Hearing Loss, Noise-Induced / Q000150:complications; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D008875:Middle Aged; D009257:Nafronyl / Q000627:therapeutic use; D010470:Perceptual Masking; D014012:Tinnitus / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*
D002220:Carbamazepine; D009257:Nafronyl; D008012:Lidocaine; D001241:Aspirin